Overview

Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers

Status:
Recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Utah
Venkata Yellepeddi

Collaborator:

Center for Addiction and Mental Health

Treatments:

Amiloride